CRB Monitor Securities Database Updates
During the week of December 4 - 10, 2023, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.
Summary of the updates for the Week of December 4 - 10, 2023:
Tier |
Total # |
Active / Inactive / Pre-IPO |
Added |
Removed |
Net Change |
Tier 1A |
149 |
124 / 23 / 2 |
+0 | -0 | +0 |
Tier 1B |
718 |
567 / 149 / 2 |
+2 | -0 | +2 |
Tier 2 |
335 |
310 / 20 / 5 |
+0 | -0 | +0 |
Tier 3 |
493 |
465 / 27 / 1 |
+0 | -0 | +0 |
Total Issuances |
1,695 |
1,466 / 219 / 10 |
+2 | -0 | +2 |
Total Issuers (w/o Pre-IPOs) |
1,277 |
- |
+2 | -0 | +2 |
Total Issuers (w/ Pre-IPOs) |
1,287 |
- |
+2 | -0 | +2 |
Added 2 Tier 1B Securities:
- +1 = New CRB: (“BITA Global Cannabis Giants Index”)
- +1 = New CRB: (“BITA Medical Psychedelics, Cannabis, and Ketamine Index”)
All newly-identified CRBs during the week:
Company Name |
Tier |
Pure-Play | Sector |
Description |
1B | Yes |
Index |
The BITA Global Cannabis Giants Index is a rules-based index that aims to capture the gross total return performance of the largest global publicly listed companies with direct revenue exposure (above 50% of revenues) to the Cannabis industry. The index is ranked and weighted by market capitalization and rebalanced on a quarterly basis. Index values are disseminated on an intraday and end-of-day basis. | |
1B | Yes |
Index |
The BITA Medical Psychedelics, Cannabis, and Ketamine Index is a rules-based index that tracks the performance of companies listed on recognized exchanges in the US and Canada that derive at least 50% of their revenue from the usage of Psychedelics, Medical Cannabis, and Ketamine for medicinal and health treatment purposes. The index constituents are weighted based on their free float market capitalization, and rebalanced on a semi-annual basis. Index values are disseminated on an intraday and end-of-day basis. |